Literature DB >> 2852521

The negative inotropic effect of nicorandil is independent of cyclic GMP changes: a comparison with pinacidil and cromakalim in canine atrial muscle.

T Yanagisawa1, H Hashimoto, N Taira.   

Abstract

1. The negative inotropic effects of nicorandil, a nitrate with K-channel opening properties, have been compared with those of pinacidil, cromakalim and nifedipine, in canine right atrial muscle. 2. Cromakalim, pinacidil and nicorandil all produced a negative inotropic effect. However, even at their maximally effective concentrations, the force of contraction remained at about 10% of control levels, whereas contraction was abolished by nifedipine. 3. The pD2 values for the negative inotropic effects of cromakalim, pinacidil and nicorandil were 5.93, 5.37, and 4.35, respectively. 4. The negative inotropic effects of cromakalim (3 x 10(-5)M), pinacidil (3 x 10(-5) M and 3 x 10(-4) M) and nicorandil (3 x 10(-5) M) were not accompanied by changes in cyclic AMP and cyclic GMP levels, whereas that of 3 x 10(-4) M nicorandil was accompanied by an increase in cyclic GMP but not cyclic AMP concentrations. 5. The negative inotropic effect produced by 3 x 10(-4) M nicorandil was greatly reduced by 10(-2) M tetraethylammonium, whereas the increase in cyclic GMP produced by this concentration of nicorandil was not significantly changed. Sodium nitroprusside (10(-3) M) produced a large increase in cyclic GMP concentrations but had no significant negative inotropic effect. 6. It is concluded that the negative inotropic effects of nicorandil like those of cromakalim and pinacidil do not result from an increase in cyclic GMP concentrations. Instead these effects may be due to their action as K-channel openers.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2852521      PMCID: PMC1854162          DOI: 10.1111/j.1476-5381.1988.tb11658.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Effect of 2-nicotinamidethyl nitrate (SG 75) on coronary circulation.

Authors:  Y Uchida; N Yoshimoto; S Murao
Journal:  Jpn Heart J       Date:  1978-01

2.  Circumstantial evidence for increased potassium conductance of membrane of cardiac muscle by 2-nicotinamidoethyl nitrate (SG-75).

Authors:  T Yanagisawa; K Satoh; N Taira
Journal:  Jpn J Pharmacol       Date:  1979-10

3.  Pinacidil increases the background potassium current in single ventricular cells.

Authors:  T Iijima; N Taira
Journal:  Eur J Pharmacol       Date:  1987-09-02       Impact factor: 4.432

4.  [BAY a 1040--a highly potent Ca ++ -antagonistic inhibitor of electro-mechanical coupling processes in mammalian myocardium].

Authors:  A Fleckenstein; H Tritthart; H J Döring; K Y Byon
Journal:  Arzneimittelforschung       Date:  1972-01

5.  The effect of the duration of the action potential on contraction in the mammalian heart muscle.

Authors:  M Morad; W Trautwein
Journal:  Pflugers Arch Gesamte Physiol Menschen Tiere       Date:  1968

6.  Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists.

Authors:  R B Parker; D R Waud
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

7.  Pharmacological profile of a new coronary vasodilator drug, 2-nicotinamidoethyl nitrate (SG-75).

Authors:  N Taira; K Satoh; T Yanagisawa; Y Imai; M Hiwatari
Journal:  Clin Exp Pharmacol Physiol       Date:  1979 May-Jun       Impact factor: 2.557

8.  Cyclic GMP as possible mediator of coronary arterial relaxation by nicorandil (SG-75).

Authors:  S Holzmann
Journal:  J Cardiovasc Pharmacol       Date:  1983 May-Jun       Impact factor: 3.105

9.  Effects of nicorandil and its interaction with isoproterenol on force of contraction and cyclic nucleotide levels of canine atrial muscle: comparison with carbachol.

Authors:  M Endoh; T Iijima
Journal:  J Cardiovasc Pharmacol       Date:  1983 Sep-Oct       Impact factor: 3.105

10.  Relationship between relaxation and cyclic GMP formation caused by nicorandil in canine mesenteric artery.

Authors:  M Endoh; N Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-05       Impact factor: 3.000

View more
  17 in total

1.  Cardiovascular effects of the novel potassium channel opener bimakalim in conscious pigs after myocardial infarction: a comparative study with nicorandil.

Authors:  L J van Woerkens; N R Baas; W J van der Giessen; P D Verdouw
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

2.  Haemodynamic profile of the potassium channel activator EMD 52692 in anaesthetized pigs.

Authors:  L M Sassen; D J Duncker; B C Gho; H W Diekmann; P D Verdouw
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

Review 3.  Pharmacology of the potassium channel openers.

Authors:  G Edwards; A H Weston
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

4.  K+ channel openers activate brain sulfonylurea-sensitive K+ channels and block neurosecretion.

Authors:  H Schmid-Antomarchi; S Amoroso; M Fosset; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

5.  Paradoxical arteriole constriction compromises cytosolic and mitochondrial oxygen delivery in the isolated saline-perfused heart.

Authors:  Abigail V Giles; Junhui Sun; Armel N Femnou; Sarah Kuzmiak-Glancy; Joni L Taylor; Raul Covian; Elizabeth Murphy; Robert S Balaban
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-10-12       Impact factor: 4.733

6.  Nicorandil increases coronary blood flow predominantly by K-channel opening mechanism.

Authors:  F Yoneyama; K Satoh; N Taira
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

7.  Cardiovascular effects of SCA40, a novel potassium channel opener, in rats.

Authors:  A Michel; F Laurent; J Bompart; K Hadj-Kaddour; J P Chapat; M Boucard; P A Bonnet
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

8.  Mechanism of the vasodilatory action of nicorandil on coronary circulation in dogs.

Authors:  I Nakae; L Quan; K Hashimoto; Y Sugimoto; T Tsutamoto; M Kinoshita
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

9.  Relationship between myoglobin contents and increases in cyclic GMP produced by glyceryl trinitrate and nitric oxide in rabbit aorta, right atrium and papillary muscle.

Authors:  T Ishibashi; M Hamaguchi; K Kato; T Kawada; H Ohta; H Sasage; S Imai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

10.  The ineffectiveness of the NO-cyclic GMP signaling pathway in the atrial myocardium.

Authors:  H Nawrath; D Bäumner; J Rupp; H Oelert
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.